194 related articles for article (PubMed ID: 12788179)
1. Accelerated superfractionated radiotherapy with concomitant boost for invasive bladder cancer.
Yavuz AA; Yavuz MN; Ozgur GK; Colak F; Ozyavuz R; Cimsitoglu E; Ilis E
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):734-45. PubMed ID: 12788179
[TBL] [Abstract][Full Text] [Related]
2. Accelerated superfractionated radiotherapy with concomitant boost for locally advanced head-and-neck squamous cell carcinomas.
Morris MM; Schmidt-Ullrich RK; DiNardo L; Manning MA; Silverman L; Clay L; Johnson CR; Amir C
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):918-28. PubMed ID: 11958884
[TBL] [Abstract][Full Text] [Related]
3. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
[TBL] [Abstract][Full Text] [Related]
4. Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck.
MacKenzie R; Balogh J; Choo R; Franssen E
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):589-95. PubMed ID: 10524410
[TBL] [Abstract][Full Text] [Related]
5. Base-of-tongue carcinoma: treatment results using concomitant boost radiotherapy.
Mak AC; Morrison WH; Garden AS; Ang KK; Goepfert H; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):289-96. PubMed ID: 7673016
[TBL] [Abstract][Full Text] [Related]
6. Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.
Chen WC; Liaw CC; Chuang CK; Chen MF; Chen CS; Lin PY; Chang PL; Chu SH; Wu CT; Hong JH
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):726-33. PubMed ID: 12788178
[TBL] [Abstract][Full Text] [Related]
7. RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.
Hagan MP; Winter KA; Kaufman DS; Wajsman Z; Zietman AL; Heney NM; Toonkel LM; Jones CU; Roberts JD; Shipley WU
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):665-72. PubMed ID: 14529770
[TBL] [Abstract][Full Text] [Related]
8. Clinical radiobiology of stage T2-T3 bladder cancer.
Majewski W; Maciejewski B; Majewski S; Suwinski R; Miszczyk L; Tarnawski R
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):60-70. PubMed ID: 15337540
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy.
Cowan RA; McBain CA; Ryder WD; Wylie JP; Logue JP; Turner SL; Van der Voet J; Collins CD; Khoo VS; Read GR
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):197-207. PubMed ID: 15093917
[TBL] [Abstract][Full Text] [Related]
10. Invasive bladder carcinoma: a pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatin.
Zouhair A; Ozsahin M; Schneider D; Bauer J; Jichlinski P; Roth A; Douglas P; Miralbell R
Int J Cancer; 2001 Dec; 96(6):350-5. PubMed ID: 11745505
[TBL] [Abstract][Full Text] [Related]
11. Concomitant boost radiotherapy for muscle invasive bladder cancer.
Pos FJ; van Tienhoven G; Hulshof MC; Koedooder K; González González D
Radiother Oncol; 2003 Jul; 68(1):75-80. PubMed ID: 12885455
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
13. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.
Horwich A; Dearnaley D; Huddart R; Graham J; Bessell E; Mason M; Bliss J
Radiother Oncol; 2005 Apr; 75(1):34-43. PubMed ID: 15878099
[TBL] [Abstract][Full Text] [Related]
14. Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa.
Gwozdz JT; Morrison WH; Garden AS; Weber RS; Peters LJ; Ang KK
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):127-35. PubMed ID: 9300747
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes in treatment of invasive bladder cancer with concomitant boost and accelerated hyperfractionated radiation therapy.
Canyilmaz E; Yavuz MN; Serdar L; Uslu GH; Zengin AY; Aynaci O; Haciislamoglu E; Bahat Z; Yoney A
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):562-9. PubMed ID: 25160608
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of concomitant boost accelerated superfractionated radiotherapy for stage III cancer of the uterine cervix.
Kavanagh BD; Gieschen HL; Schmidt-Ullrich RK; Arthur D; Zwicker R; Kaufman N; Goplerud DR; Segreti EM; West RJ
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):561-8. PubMed ID: 9231680
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment.
Hafeez S; McDonald F; Lalondrelle S; McNair H; Warren-Oseni K; Jones K; Harris V; Taylor H; Khoo V; Thomas K; Hansen V; Dearnaley D; Horwich A; Huddart R
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):115-122. PubMed ID: 28586948
[TBL] [Abstract][Full Text] [Related]
18. Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of Protocol 83-08 of the Radiation Therapy Oncology Group.
Cox JD; Guse C; Asbell S; Rubin P; Sause WT
Int J Radiat Oncol Biol Phys; 1988 Dec; 15(6):1331-6. PubMed ID: 3058657
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
20. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
Garden AS; Morrison WH; Ang KK; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
